Compare Stocks: MTD, BRKR, RGEN, and TECH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRKR Bruker	$64.34 +4.2%	$57.81	$28.53 ▼ $64.54	$9.40B	1.29	1.89 million shs	1.98 million shs
MTD Mettler-Toledo International	$1,378.70 -0.7%	$1,231.02	$1,023.05 ▼ $1,525.17	$28.05B	1.24	152,613 shs	203,522 shs
RGEN Repligen	$143.60 +1.7%	$134.14	$100.99 ▼ $175.77	$7.97B	1.06	1.17 million shs	1.04 million shs
TECH Bio-Techne	$72.03	$62.56	$43.19 ▼ $72.36	$11.28B	1.29	4.01 million shs	6.05 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRKR Bruker	+4.13%	+3.52%	+6.91%	+75.27%	+57.31%
MTD Mettler-Toledo International	-0.91%	+3.73%	+7.77%	+7.74%	+8.89%
RGEN Repligen	+1.68%	+4.36%	+5.25%	+21.38%	+16.89%
TECH Bio-Techne	0.00%	+0.36%	+1.95%	+30.21%	+24.81%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRKR Bruker	$64.34 +4.2%	$57.81	$28.53 ▼ $64.54	$9.40B	1.29	1.89 million shs	1.98 million shs
MTD Mettler-Toledo International	$1,378.70 -0.7%	$1,231.02	$1,023.05 ▼ $1,525.17	$28.05B	1.24	152,613 shs	203,522 shs
RGEN Repligen	$143.60 +1.7%	$134.14	$100.99 ▼ $175.77	$7.97B	1.06	1.17 million shs	1.04 million shs
TECH Bio-Techne	$72.03	$62.56	$43.19 ▼ $72.36	$11.28B	1.29	4.01 million shs	6.05 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRKR Bruker	+4.13%	+3.52%	+6.91%	+75.27%	+57.31%
MTD Mettler-Toledo International	-0.91%	+3.73%	+7.77%	+7.74%	+8.89%
RGEN Repligen	+1.68%	+4.36%	+5.25%	+21.38%	+16.89%
TECH Bio-Techne	0.00%	+0.36%	+1.95%	+30.21%	+24.81%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BRKR Bruker	2.44	Hold	$56.79	-11.74% Downside
MTD Mettler-Toledo International	2.46	Hold	$1,408.55	2.16% Upside
RGEN Repligen	2.88	Moderate Buy	$166.43	15.90% Upside
TECH Bio-Techne	2.12	Hold	$68.08	-5.49% Downside

Current Analyst Ratings Breakdown

Latest MTD, BRKR, RGEN, and TECH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2026	RGEN Repligen	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$180.00 ➝ $185.00
7/29/2026	RGEN Repligen	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$165.00 ➝ $175.00
7/21/2026	MTD Mettler-Toledo International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
7/15/2026	BRKR Bruker	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
7/14/2026	RGEN Repligen	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
7/9/2026	TECH Bio-Techne	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Sector Perform	$62.00 ➝ $73.00
7/8/2026	BRKR Bruker	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$44.00 ➝ $60.00
7/7/2026	MTD Mettler-Toledo International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
7/7/2026	RGEN Repligen	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy
7/7/2026	BRKR Bruker	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$60.00 ➝ $70.00
7/7/2026	RGEN Repligen	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$185.00

(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BRKR Bruker	$3.44B	2.85	$3.52 per share	18.29	$16.28 per share	3.95
MTD Mettler-Toledo International	$4.03B	6.92	$49.29 per share	27.97	($1.16) per share	-1,188.54
RGEN Repligen	$738.26M	10.97	$3.47 per share	41.33	$37.44 per share	3.84
TECH Bio-Techne	$1.22B	9.25	$2.45 per share	29.46	$12.24 per share	5.88

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BRKR Bruker	-$8.60M	-$0.24	N/A	26.37	1.98	-0.65%	11.60%	4.25%	8/4/2026 (Estimated)
MTD Mettler-Toledo International	$869.19M	$42.64	32.33	26.70	2.90	21.40%	-622.80%	24.97%	N/A
RGEN Repligen	$48.89M	$0.90	196.71	58.85	2.67	5.29%	5.30%	3.79%	N/A
TECH Bio-Techne	$73.40M	$0.69	104.39	40.93	8.58	9.05%	13.57%	10.66%	8/5/2026 (Estimated)

Latest MTD, BRKR, RGEN, and TECH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q4 2026	TECH Bio-Techne	$0.52	N/A	N/A	N/A	$314.65 million	N/A
8/4/2026	Q2 2026	BRKR Bruker	$0.38	N/A	N/A	N/A	$853.57 million	N/A
7/30/2026	Q2 2026	MTD Mettler-Toledo International	$10.80	$11.46	+$0.66	$11.55	$1.03 billion	$1.03 billion
7/28/2026	Q2 2026	RGEN Repligen	$0.4470	$0.54	+$0.0930	$0.09	$201.59 million	$204.13 million
5/7/2026	Q1 2026	MTD Mettler-Toledo International	$8.70	$8.91	+$0.21	$8.33	$943.14 million	$947.13 million
5/6/2026	Q1 2026	BRKR Bruker	$0.23	$0.31	+$0.08	$0.02	$795.62 million	$823.40 million
5/6/2026	Q3 2026	TECH Bio-Techne	$0.55	$0.53	-$0.02	$0.32	$316.11 million	$311.42 million
5/5/2026	Q1 2026	RGEN Repligen	$0.38	$0.48	+$0.10	$0.15	$192.05 million	$194.26 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BRKR Bruker	$0.20	0.31%	+4.56%	N/A	N/A
MTD Mettler-Toledo International	N/A	N/A	N/A	N/A	N/A
RGEN Repligen	N/A	N/A	N/A	N/A	N/A
TECH Bio-Techne	$0.32	0.44%	N/A	46.38%	N/A

Latest MTD, BRKR, RGEN, and TECH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/14/2026	BRKR Bruker	quarterly	$0.05	0.35%	6/22/2026	6/22/2026	7/7/2026
5/6/2026	TECH Bio-Techne	quarterly	$0.08	0.72%	5/18/2026	5/18/2026	5/29/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BRKR Bruker	0.67	1.55	0.72
MTD Mettler-Toledo International	N/A	1.20	0.84
RGEN Repligen	0.26	9.05	7.78
TECH Bio-Techne	0.10	4.49	3.18

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BRKR Bruker	79.52%
MTD Mettler-Toledo International	95.07%
RGEN Repligen	97.64%
TECH Bio-Techne	98.95%

Insider Ownership

Company	Insider Ownership
BRKR Bruker	27.20%
MTD Mettler-Toledo International	0.71%
RGEN Repligen	0.60%
TECH Bio-Techne	1.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BRKR Bruker	11,085	152.23 million	110.82 million	Optionable
MTD Mettler-Toledo International	18,100	20.21 million	20.07 million	Optionable
RGEN Repligen	2,000	56.41 million	56.07 million	Optionable
TECH Bio-Techne	3,100	156.57 million	154.53 million	Optionable

MTD, BRKR, RGEN, and TECH Headlines

Recent News About These Companies

Bank of Nova Scotia Sells 38,334 Shares of Bio-Techne Corp $TECH

1 hour ago | marketbeat.com

Arrowstreet Capital Limited Partnership Purchases New Shares in Bio-Techne Corp $TECH

1 hour ago | marketbeat.com

Intrinsic Edge Capital Management LLC Buys Shares of 110,000 Bio-Techne Corp $TECH

July 30 at 6:08 AM | marketbeat.com

Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?

July 29 at 10:05 AM | zacks.com

Bio-Techne (TECH) to Release Quarterly Earnings on Wednesday

July 29 at 7:55 AM | marketbeat.com

INTURAI FAST TRACKS DOMECOMMAND COMMERCIALISATION WITH EUROPEAN DEFENCE TECH HUB AND SINGAPORE AIR FORCE

July 29 at 4:00 AM | prnewswire.com

Dimensional Fund Advisors LP Boosts Holdings in Bio-Techne Corp $TECH

July 29 at 3:36 AM | marketbeat.com

Technegas Secures Preferred Status in Landmark U.S. Lung Imaging Guidelines

July 28 at 7:31 PM | tipranks.com

Bio-Techne (NASDAQ:TECH) Sets New 52-Week High - Should You Buy?

July 28 at 3:59 PM | marketbeat.com

Ruane Cunniff & Goldfarb L.P. Boosts Stock Position in Bio-Techne Corp $TECH

July 28 at 6:47 AM | marketbeat.com

Eversept Partners LP Trims Stake in Bio-Techne Corp $TECH

July 28 at 6:31 AM | marketbeat.com

Maverick Capital Ltd. Has $247.70 Million Stock Holdings in Bio-Techne Corp $TECH

July 28 at 6:00 AM | marketbeat.com

Ashford Capital Management Inc. Trims Stake in Bio-Techne Corp $TECH

July 28 at 3:44 AM | marketbeat.com

American Capital Management Inc. Boosts Stock Holdings in Bio-Techne Corp $TECH

July 28 at 3:43 AM | marketbeat.com

Brokerages Set Bio-Techne Corp (NASDAQ:TECH) Target Price at $68.08

July 28 at 3:29 AM | americanbankingnews.com

Bio-Techne Corp $TECH Shares Sold by Bradley Foster & Sargent Inc. CT

July 27, 2026 | marketbeat.com

First Trust Advisors LP Raises Stake in Bio-Techne Corp $TECH

July 26, 2026 | marketbeat.com

Bio-Techne Corp $TECH Shares Sold by Aristotle Atlantic Partners LLC

July 26, 2026 | marketbeat.com

Allspring Global Investments Holdings LLC Has $7.82 Million Stake in Bio-Techne Corp $TECH

July 24, 2026 | marketbeat.com

Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of "Hold" from Analysts

July 23, 2026 | marketbeat.com

Jennison Associates LLC Invests $6.23 Million in Bio-Techne Corp $TECH

July 22, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MTD, BRKR, RGEN, and TECH Company Descriptions

Bruker NASDAQ:BRKR

$64.34 +2.60 (+4.21%)

Closing price 07/30/2026 04:00 PM Eastern

Extended Trading

$64.38 +0.04 (+0.06%)

As of 07/30/2026 07:37 PM Eastern

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Mettler-Toledo International NYSE:MTD

$1,378.70 -9.63 (-0.69%)

Closing price 07/30/2026 03:59 PM Eastern

Extended Trading

$1,418.50 +39.80 (+2.89%)

As of 04:00 AM Eastern

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

Repligen NASDAQ:RGEN

$143.60 +2.37 (+1.68%)

Closing price 07/30/2026 04:00 PM Eastern

Extended Trading

$145.00 +1.40 (+0.97%)

As of 04:34 AM Eastern

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Bio-Techne NASDAQ:TECH

$72.03 0.00 (0.00%)

Closing price 07/30/2026 04:00 PM Eastern

Extended Trading

$72.47 +0.44 (+0.61%)

As of 07/30/2026 07:34 PM Eastern

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MTD, BRKR, RGEN, and TECH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MTD, BRKR, RGEN, and TECH Earnings

Compare Dividends

Latest MTD, BRKR, RGEN, and TECH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MTD, BRKR, RGEN, and TECH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MTD, BRKR, RGEN, and TECH Company Descriptions

Bruker NASDAQ:BRKR

Mettler-Toledo International NYSE:MTD

Repligen NASDAQ:RGEN

Bio-Techne NASDAQ:TECH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools